Buy This, Not That: A Big Dose of 5 Big Pharma Stocks
Which of these five drugmakers stocks hands out a prescription for portfolio health?
Monday Takeaways: A Perfect Storm of Politics, Earnings, and Economic Data
Tech stocks took a beating last week… the markets jumped in early Monday trading… and some big data awaits. Here’s what’s affecting your money this week…
Buy This, Not That: Are the Big Banks Big Buys?
While the big banks are touting impressive headline numbers, with record highs and substantial profit increases, there’s something lurking under the surface…
Monday Takeaways: Bank on Trouble Coming
Forget the back-to-back-to-back market highs. The latest bank earnings reports are a warning…
Dealmaker’s Diary: Add This Undervalued Retail Pioneer to Your Cart
This bulk retail pioneer has been serving up jumbo-sized gains over the past few years. Get the ticker here.
Buy This, Not That: Put These Controversial Stocks on Your “Buy” List
It doesn’t matter what they do or where they do it. Are they making money? These five Chinese stocks are.
Monday Takeaways: The Magnificent Seven’s Creative Destruction
Barron’s is out with a piece that suggests it’s time to get out of the Magnificent Seven. Here’s why that’s wrong.
Buy This, Not That: Summer Sizzlers and Vacation Busts
As summer travel kicks into high gear, here are six travel and leisure stocks that should be either added to your bucket list… or be given one-star reviews.
The Most Obvious Catalyst for a Bitcoin Rally
Crypto investors got nervous after Bitcoin recently dropped 8% in one day. But there’s a big reason Bitcoin is set to resume its rally.
Monday Takeaways: All Is Not Quiet on Wall Street
It should be a quiet holiday week on Wall Street… but investors need to watch out. Here’s why…